Veterinary Medicines

LOTAGEN 360 mg/g koncentrát na kožný roztok

Authorised
  • Policresulen
Download as PDF

Product identification

Medicine name:
LOTAGEN 360 mg/g koncentrát na kožný roztok
Active substance:
  • Policresulen
Target species:
  • Cattle
  • Horse
  • Pig
  • Sheep
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Policresulen
    360.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Concentrate for cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • All relevant tissues
        no withdrawal period
    • Horse
      • All relevant tissues
        no withdrawal period
    • Pig
      • All relevant tissues
        no withdrawal period
    • Sheep
      • All relevant tissues
        no withdrawal period
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD08AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/0031/96-S
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 16/11/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."